SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-17-002903
Filing Date
2017-01-19
Accepted
2017-01-19 15:44:02
Documents
1
Period of Report
2017-01-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v457179_4.html 4  
1 OWNERSHIP DOCUMENT v457179_4.xml 4 5488
  Complete submission text file 0001144204-17-002903.txt   7003
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Issuer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O MONTAUR CAPITAL PARTNERS 152 WEST 57TH STREET, 4TH FLOOR NEW YORK NY 10019
Business Address
GOLDBERG MICHAEL M (Reporting) CIK: 0000905011 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35076 | Film No.: 17535907